Cited 8 times in
Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김자경 | - |
dc.contributor.author | 박준용 | - |
dc.contributor.author | 안상훈 | - |
dc.contributor.author | 이혜원 | - |
dc.contributor.author | 한광협 | - |
dc.date.accessioned | 2020-02-11T06:31:23Z | - |
dc.date.available | 2020-02-11T06:31:23Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 1542-3565 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/174711 | - |
dc.description.abstract | Hepatitis B virus (HBV) suppression with nucleot(s)ide analogue therapy reduces the risk of hepatic decompensation and hepatocellular carcinoma (HCC) in patients with advanced liver disease.1 In the present era of potent antiviral therapies, the prognostic significance of the serum HBV DNA level as a biological gradient has substantially diminished; the majority of treated patients achieve virologic suppression.2,3 After control of viremia, a higher baseline fibrosis level is a useful predictor for disease progression.4 Few "prospective" studies on the effects of antiviral agents, especially in chronic hepatitis B (CHB) patients with advanced liver disease, have been reported. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | W.B. Saunders | - |
dc.relation.isPartOf | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Hye Won Lee | - |
dc.contributor.googleauthor | Jun Yong Park | - |
dc.contributor.googleauthor | Sang Gyune Kim | - |
dc.contributor.googleauthor | Won Young Tak | - |
dc.contributor.googleauthor | Hyung Joon Yim | - |
dc.contributor.googleauthor | Byoung Kuk Jang | - |
dc.contributor.googleauthor | Moon Young Kim | - |
dc.contributor.googleauthor | Byung Ik Kim | - |
dc.contributor.googleauthor | Jin-Woo Lee | - |
dc.contributor.googleauthor | Ki Tae Yoon | - |
dc.contributor.googleauthor | Jae Youn Cheong | - |
dc.contributor.googleauthor | So Young Kwon | - |
dc.contributor.googleauthor | Tae Yeob Kim | - |
dc.contributor.googleauthor | Si Hyun Bae | - |
dc.contributor.googleauthor | Yeon Seok Seo | - |
dc.contributor.googleauthor | Jung Hyun Kwon | - |
dc.contributor.googleauthor | Dong Joon Kim | - |
dc.contributor.googleauthor | Ja-Kyung Kim | - |
dc.contributor.googleauthor | Soung Won Jeong | - |
dc.contributor.googleauthor | Sungmin Myoung | - |
dc.contributor.googleauthor | Sang Hoon Ahn | - |
dc.contributor.googleauthor | Kwang-Hyub Han | - |
dc.identifier.doi | 10.1016/j.cgh.2019.01.044 | - |
dc.contributor.localId | A00852 | - |
dc.contributor.localId | A01675 | - |
dc.contributor.localId | A02226 | - |
dc.contributor.localId | A03318 | - |
dc.contributor.localId | A04268 | - |
dc.relation.journalcode | J02981 | - |
dc.identifier.eissn | 1542-7714 | - |
dc.identifier.pmid | 30731195 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S1542356519300916 | - |
dc.contributor.alternativeName | Kim, Ja Kyung | - |
dc.contributor.affiliatedAuthor | 김자경 | - |
dc.contributor.affiliatedAuthor | 박준용 | - |
dc.contributor.affiliatedAuthor | 안상훈 | - |
dc.contributor.affiliatedAuthor | 이혜원 | - |
dc.contributor.affiliatedAuthor | 한광협 | - |
dc.citation.volume | 17 | - |
dc.citation.number | 13 | - |
dc.citation.startPage | 2811 | - |
dc.citation.endPage | 2813.e1 | - |
dc.identifier.bibliographicCitation | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, Vol.17(13) : 2811-2813.e1, 2019 | - |
dc.identifier.rimsid | 63501 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.